# Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

> **NCT05730010** · — · COMPLETED · sponsor: **Indiana University** · enrollment: 289 (actual)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05730010
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-16
- **Primary completion:** 2023-06-26
- **Final completion:** 2023-06-26
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2023-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05730010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05730010, "Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05730010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*